Tonum press room
Welcome to the Tonum press room. Select a button below to read our press releases, about us in the news, or to find our media contacts.
Hello, and Welcome to the Tonum Health Newsroom.
We’re glad you’re here. Whether you're reporting on weight loss or brain health and cognitive function, exploring innovation in our industry, or simply learning more about who we are and the benefits of supplements — this is the place to start.
In this newsroom, you’ll find:
- Direct access to Tonum Health’s public relations team
- Spokesperson availability for interviews or quotes
- Press releases and company announcements
- Background information about our mission, leadership, and journey
- Recent media coverage and features
On deadline? Need a quick quote or a timely connection with the right expert? We’re here to help and happy to support your coverage in any way we can.
Thank you for your interest in Tonum Health. We look forward to assisting you.
Press Releases
For inquiries about Tonum products, please reach out to the contact on our PR team:
Leigh Fazzina
Public Relations Strategist
Tonum
400 N Flagler Dr.
Suite 1506
West Palm Beach, Florida 33401
leigh@tonum.com
Company Name
Tonum Health by Prostasis LLC.
Description
Founded in 2016, Prostasis develops science-backed natural supplements designed to optimize brain health, prevent neurodegeneration, and boost weight loss and metabolic health. Our team of pharmaceutical researchers and wellness experts is dedicated to creating natural products rooted in research—empowering individuals to take control of their long-term health.
Employees
10
Headquarters
West Palm Beach, Florida
Businesses
Nutraceuticals
Natural Supplements
R&D Expenses To Date
$5.2M
Products
Tonum Health is a research-backed nutritional supplement company that develops weight loss and cognitive health products for consumers and health care providers.
Motus
Human clinical trial = 12% weight loss in 6 months*
Preserves lean muscle mass >80%*
Supports healthy cholesterol**
Improves energy efficiency**
Optimizes GLP-1 by 812% over GLP-1 alone in mice**
Sustains weight loss after GLP-1 discontinuation**
Nouro
Prevents accumulation of amyloid plaque**
Reduction of neuroinflammation**
Promotion of neuronal growth**
Coming Soon
Nouro and Motus bar, protein bars with 18g of protein plus all the added benefits from Nouro and Motus supplements.
Nouro and Motus drink stick packs. Electrolyte stick pack with Motus and Nouro active ingrediets.
Pipeline 2025-2026
Human Clinical Study
Motus - 100 patient 180 day clinical study - Status: Completed and extended another 180 days
Motus - 80 patient 180 day clinical study - Status: Q1 2026
Nouro - 60 patient cognition study - Status: Q3 2026
Nouro - 40 patient concussion study - Status: Q4 2026
Senior Leadership
Lance Converse, CEO
Channing Capacchione, VP of Marketing
Nicholas Moore, PhD, Chief Scientific Officer
Linda Anegawa, MD, Chief Medical Advisor
Mark Brosso, Founder
* Prostasis open label human study completed July 2026
**Prostasis Funded Duke run rodent studies started 2016 and continuing through today